BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6605819)

  • 1. Absorbance nephelometry of C1q-precipitable immune complexes: method comparisons and clinical correlations.
    Levinson SS; Goldman J
    Clin Chem; 1983 Dec; 29(12):2082-6. PubMed ID: 6605819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical analysis of five immune complex screening assays: patterns of detection in patients with rheumatoid arthritis, systemic lupus erythematosus, infectious endocarditis, and diabetes mellitus.
    Kilpatrick JM; Virella G
    Diagn Immunol; 1983; 1(2):57-63. PubMed ID: 6388965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorbance nephelometry of immune complexes by reaction with anti-IgG after treatment with polyethylene glycol.
    Levinson SS; Goldman J
    Clin Chem; 1983 Dec; 29(12):2035-9. PubMed ID: 6605818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-IgG binding test to assay circulating IgG-containing immune complexes from polyethylene glycol precipitates.
    Levinson SS; Goldman JO; Feldkamp CS
    Clin Chem; 1984 Sep; 30(9):1502-6. PubMed ID: 6235980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of circulating Clq precipitable immune complexes by a nephelometric type assay after polyethylene glycol extraction in model system.
    Levinson SS; Goldman J
    Am J Clin Pathol; 1983 Apr; 79(4):451-7. PubMed ID: 6188360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
    Antes U; Heinz HP; Loos M
    J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
    Medof ME
    J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-IgG type test to assay circulating immune complexes from polyethylene glycol precipitates compared with C1q binding and Raji cell tests.
    Levinson SS; Goldman J
    Clin Biochem; 1984 Dec; 17(6):341-4. PubMed ID: 6335066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of anti-C1q capture assay for detecting circulating immune complexes and comparison with polyethylene glycol-immunoglobulin G, C1q-binding, and Raji cell methods.
    Levinson SS; Goldman JO
    J Clin Microbiol; 1987 Aug; 25(8):1567-9. PubMed ID: 2957387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some studies on the polyethylene glycol turbidity method for detecting immune complexes in serum.
    Kilpatrick DC; Weston J; Irvine WJ
    Ann Clin Biochem; 1981 Nov; 18(Pt 6):373-7. PubMed ID: 6976150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of assays for circulating immune complexes.
    Endo L; Corman LC; Panush RS
    Med Clin North Am; 1985 Jul; 69(4):623-36. PubMed ID: 3903373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
    Mooney NA; Hay FC; Poulton TA
    Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.
    Nydegger UE; Lambert PH; Gerber H; Miescher PA
    J Clin Invest; 1974 Aug; 54(2):297-309. PubMed ID: 4847246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A PEG-precipitation laser nephelometer technique for detection and characterization of circulating immune complexes in human sera.
    Krapf F; Renger D; Schedel I; Leiendecker K; Leyssens H; Deicher H
    J Immunol Methods; 1982 Oct; 54(1):107-17. PubMed ID: 7142715
    [No Abstract]   [Full Text] [Related]  

  • 15. [The importance of using various methods in the determination of serum immune complex levels].
    Mijusković Z; Radojicić C; Lilić D; Todorović P; Dujić A
    Vojnosanit Pregl; 1989; 46(4):256-60. PubMed ID: 2800418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune complexes in systemic sclerosis; detection by C1q binding, K-cell inhibition and Raji cell radioimmunoassays.
    Hughes P; Cunningham J; Day M; Fitzgerald JC; French MA; Wright JK; Rowell NR
    J Clin Lab Immunol; 1983 Mar; 10(3):133-8. PubMed ID: 6601718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laser-nephelometric detection of soluble immune complexes.
    Hudák J; Huszta E; Pokorny G; Varga L
    Acta Med Acad Sci Hung; 1980; 37(4):381-7. PubMed ID: 7234305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating immune complexes in malignant diseases increased detection rate by simultaneous use of three assay methods.
    Krapf F; Renger D; Schedel I; Fricke M; Kemper A; Deicher H
    Cancer Immunol Immunother; 1983; 15(2):138-43. PubMed ID: 6603263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1q and immune complexes in liver cirrhosis sera.
    Yoshida H; Sato M; Watanabe S; Nishimaki T; Morito T; Kasukawa R; Nakai M
    Tohoku J Exp Med; 1983 May; 140(1):73-9. PubMed ID: 6603034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A C1Q enzyme-linked immunosorbent assay (ELISA) using polyethylene glycol for immune complexes.
    Lunde MN
    Am J Trop Med Hyg; 1983 Mar; 32(2):392-6. PubMed ID: 6340543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.